PCR-DIRECTED PREEMPTIVE THERAPY WITH GANCICLOVIR TO REDUCE CMV ASSOCIATED MORTALITY FOLLOWING ALLOGENEIC STEM-CELL TRANSPLANTATION

Authors
HEBART H KLINGEBIEL T LOFFLER J JAHN G MULLER CA KANZ I EINSELE H
Citation
H. Hebart et al., PCR-DIRECTED PREEMPTIVE THERAPY WITH GANCICLOVIR TO REDUCE CMV ASSOCIATED MORTALITY FOLLOWING ALLOGENEIC STEM-CELL TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 636-636
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
24
Issue
9
Year of publication
1996
Pages
636 - 636
Database
ISI
SICI code
0301-472X(1996)24:9<636:PPTWGT>2.0.ZU;2-G